Your browser doesn't support javascript.
loading
Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.
Merrill, J T; van Vollenhoven, R F; Buyon, J P; Furie, R A; Stohl, W; Morgan-Cox, M; Dickson, C; Anderson, P W; Lee, C; Berclaz, P-Y; Dörner, T.
Affiliation
  • Merrill JT; Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • van Vollenhoven RF; Department of Medicine, Karolinska Institute, Stockholm, Sweden.
  • Buyon JP; New York University School of Medicine, New York, New York, USA.
  • Furie RA; Division of Rheumatology and Allergy-Clinical Immunology, Hofstra North Shore-LIJ School of Medicine, Great Neck, New York, USA.
  • Stohl W; Rheumatology, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
  • Morgan-Cox M; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Dickson C; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Anderson PW; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Lee C; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Berclaz PY; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Dörner T; Medicine/Rheumatology and Clin Immunology, Charité Universitätsmedizin, Berlin, Germany.
Ann Rheum Dis ; 75(2): 332-40, 2016 Feb.
Article in En | MEDLINE | ID: mdl-26293163
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B-Cell Activating Factor / Lupus Erythematosus, Systemic / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Rheum Dis Year: 2016 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B-Cell Activating Factor / Lupus Erythematosus, Systemic / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Rheum Dis Year: 2016 Type: Article Affiliation country: United States